MIR9-2: A Potential Drug Target and Biomarker (G407047)

Target Name: MIR9-2

NCBI ID: G407047

MIR9-2

MIR9-2: A Potential Drug Target and Biomarker

MIR9-2 (hsa-miR-9-5p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns make it an attractive target for researchers to study and develop new treatments.

MIR9-2 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells throughout the body and is involved in regulating gene expression, cell growth, and apoptosis.

One of the key features of MIR9-2 is its unique structure. It is composed of 19 amino acid residues and has a calculated molecular weight of 20.8 kDa. Its unique expression patterns, such as its highly expressed level in the liver and its low expression in other tissues, make it an ideal candidate for drug targeting.

MIR9-2 has also been shown to play a role in cancer development and progression. Studies have shown that MIR9-2 is highly expressed in various types of cancer, including liver cancer, breast cancer, and colorectal cancer. Additionally, MIR9-2 has been shown to promote the growth and survival of cancer cells, making it a potential drug target.

Another promising aspect of MIR9-2 is its expression pattern in human tissues. MIR9-2 has been shown to be highly expressed in various tissues, including the liver, pancreas, and spleen. Its low expression in other tissues, such as muscle and brain, suggests that it may not be a useful biomarker for these diseases.

In addition to its potential as a drug target, MIR9-2 has also been shown to be a potential biomarker for various diseases. Its expression patterns have been used to study the effects of various drugs on cancer growth and progression. For example, studies have shown that inhibiting MIR9-2 has potential as a new treatment option for breast cancer.

Another potential application of MIR9-2 is its role in the regulation of cellular processes. MIR9-2 has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and apoptosis. Its role in these processes makes it an attractive candidate for new therapies.

In conclusion, MIR9-2 is a unique and promising molecule that has the potential to be a drug target and biomarker for various diseases. Its unique structure and expression patterns make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of MIR9-2 in various biological processes and to develop new treatments based on its properties.

Protein Name: MicroRNA 9-2

The "MIR9-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR9-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets